CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 62 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,839,000 | -19.1% | 207,500 | 0.0% | 0.47% | -29.6% |
| Q2 2018 | $4,743,000 | -19.7% | 207,500 | 0.0% | 0.66% | -36.1% |
| Q1 2018 | $5,903,000 | +57.5% | 207,500 | +16.9% | 1.04% | +13.8% |
| Q4 2017 | $3,747,000 | +16.2% | 177,500 | 0.0% | 0.91% | +0.1% |
| Q3 2017 | $3,225,000 | +17.2% | 177,500 | 0.0% | 0.91% | -10.5% |
| Q2 2017 | $2,751,000 | -10.2% | 177,500 | 0.0% | 1.02% | -43.7% |
| Q1 2017 | $3,065,000 | +118.8% | 177,500 | +39.2% | 1.81% | +56.3% |
| Q4 2016 | $1,401,000 | -29.9% | 127,500 | 0.0% | 1.16% | -28.5% |
| Q3 2016 | $1,999,000 | -16.4% | 127,500 | -45.6% | 1.62% | -32.0% |
| Q2 2016 | $2,392,000 | -42.2% | 234,179 | -27.1% | 2.38% | -49.9% |
| Q1 2016 | $4,141,000 | -38.2% | 321,023 | 0.0% | 4.75% | -19.7% |
| Q4 2015 | $6,700,000 | – | 321,023 | – | 5.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |